Generic CellCept is used for preventing organ rejection following kidney, liver or heart transplants. This medicine is used in combination with other medicines.
Generic Cyklokapron is used for short-term use (2 to 8 days) for reducing or preventing excessive bleeding and reducing the need for blood clotting factor transfusions during or after tooth extractions in patients with hemophilia.
Generic Demadex is used for treatment of edema (swelling) associated with heart, kidney, or liver failure or conditions when there is excess body water. It is also used alone or with other medicines to treat high blood pressure.
Generic Imuran is used for preventing kidney transplant rejection along with other medicine. It may also be used to treat signs and symptoms of active rheumatoid arthritis.
Generic Neoral is used for preventing the rejection of organ transplants (kidney, liver, and heart). This medicine is also used to treat psoriasis and rheumatoid arthritis in certain patients.
Hi.
just want to say thanks for your promt and efficient service.. The tablets arrived well within the timeframe given.. Have passed on your
address, dont know wheather its been used or not..
Best regards... and happy St Patricks from the Irish in France..
- Kieran
Although pregnancy is generally considered to be a safe time during which hormonal changes protect women from psychiatric disorders, this is a myth, say researchers from Massachusetts General Hospital, the University of California, Los Angeles, and Emory University.
In a study of 201 pregnant women, 65 stopped antidepressant treatment around the time of conception; of those, [...]]]...
Hanford Pharmaceuticals is voluntarily recalling four lots (379,975 vials) of Cefazolin for Injection, USP, 1 g/10-ml vials, an antibiotic used in hospitals to treat skin and skin structure, respiratory, and other infections.
Some lots of the product’s active ingredient were contaminated with Bacillus pumilus, Staphylococcus hom-inis, Propionibacterium acnes, or Micro-coccus luteus. Such microbial contamination may be [...]]]...
Berlex, Inc., a U.S. affiliate of Schering AG, Germany, has announced the FDA’s approval of a monophasic oral contraceptive (Yaz). This is the first tablet to combine 20 mcg of ethinyl estradiol generic with 3 mg of the progestin drospirenone.
This 24-day regimen causes less hormonal fluctuation than traditional oral contraceptives providing a 21-day course.
In a [...]]]...
Genentech, Inc., and Biogen Idec have announced the FDA’s approval of the therapeutic antibody rituximab (Rituxan) in combination with generic methotrexate (MTX) for adults with moderately to severely active rheumatoid arthritis (RA) who have not responded adequately to one or more tumor necrosis factor antagonist therapies. This is the first RA therapy that targets immune [...]]]...
Two prescription creams used to treat eczema will now carry strong warnings about the possible risk of skin cancer, lymphoma, and other cancers associated with their use.
The packaging for pimecrolimus (Elidel, Novartis AG) and medication tacrolimus (Protopic generic, Astellas Pharma) will contain “black-box” warnings—the strongest type used in the U.S.—10 months after the agency first [...]]]...
